BiotechTube

bisoprolol + placebo

ApprovedTerminated
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Aortic Stenosis

Conditions

Aortic Stenosis

Trial Timeline

Jul 1, 2012 → May 1, 2014

NCT ID
NCT01579058

About bisoprolol + placebo

bisoprolol + placebo is a approved stage product being developed by Merck for Aortic Stenosis. The current trial status is terminated. This product is registered under clinical trial identifier NCT01579058. Target conditions include Aortic Stenosis.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT01579058ApprovedTerminated

Competing Products

20 competing products in Aortic Stenosis

See all competitors
ProductCompanyStageHype Score
Apixaban 5 MG + Apixaban 2.5 MG + WarfarinArtivionPhase 3
72
EdoxabanDaiichi SankyoPhase 3
77
NOAC + DAPTDaiichi SankyoApproved
85
Ticagrelor + PlaceboAstraZenecaPhase 2
52
Rosuvastatin + PlaceboAstraZenecaPhase 3
77
candesartan + placeboAstraZenecaPhase 3
77
SugammadexMerckApproved
85
Metformin Glucophage 500mg (IR) tablets M90 + Placebo Oral TabletMerckPhase 2/3
65
Pelacarsen (TQJ230) 80mg + Matching placeboNovartisPhase 2
52
fluvastatinNovartisPhase 2
52
ACZ885 + PlaceboNovartisPhase 2
52
Evolocumab + PlaceboAmgenPhase 1
32
atorvastatin (Lipitor)PfizerApproved
84
Apixaban + Standard of carePfizerPhase 3
76
Ataciguat + PlaceboSanofiPhase 1
32
Ataciguat (HMR1766)SanofiPhase 2
51
Haemocomplettan® P + Saline solutionCSLPhase 2
51
Rivaroxaban (Xarelto, BAY59-7939) + Acetylsalicylic Acid (ASA) + Clopidogrel + Rivaroxaban (Xarelto, BAY59-7939) + Vitamin K antagonist (VKA)BayerPhase 3
74
Acetylsalicylic acid + Clopidogrel + RivaroxabanBayerPhase 3
74
DesfluraneBaxterApproved
82

Other Products from Merck

DuleraApproved
85
ImipenemApproved
85
Mavenclad®Approved
85
raltegravir + PlaceboApproved
85
alendronate sodiumApproved
85